LauraLHolmanMDMS

Obstetrics & Gynecology • Oklahoma City, OK

Gynecologic Oncology

Associate Professor

Join to view full profile

Dr. Holman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Holman's full profile

Already have an account?

Office
800 NE 10th St
Oklahoma City, OK 73104

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2011 - 2015
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2007 - 2011
University of Illinois College of MedicineClass of 2007

Certifications & Licensure

OK State Medical License 2015 - 2025
TX State Medical License 2013 - 2017
RI State Medical License 2007 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

29 citations
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis
Kimberly Levinson, Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan
Gynecologic Oncology. 2021-09-01
13 citations
An Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers
T. Castellano, Kathleen N. Moore, Laura L. Holman
Clinical Therapeutics. 2018-03-01
33 citations
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Brian M Slomovitz, Virginia L Filiaci, Joan L Walker, Michael C Taub, Karen A Finkelstein
Gynecologic Oncology. 2022-03-01